US oil producer Continental Resources drops fraud lawsuit against rival Hess
Continental said that Hess, which operates hundreds of wells in North Dakota, artificially inflated midstream service fees by entering into agreements with its own subsidiaries.
Continental, Hess and Chevron (CVX.N), opens new tab, which closed its acquisition of Hess last week, did not respond to requests for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 minutes ago
- Reuters
AstraZeneca beats profit expectations on robust drug sales, U.S. demand
July 29 (Reuters) - AstraZeneca (AZN.L), opens new tab beat second-quarter profit forecasts on robust sales of cancer, heart and kidney disease drugs and strong demand in the U.S., where it has invested $50 billion to expand amid tariff threats from President Donald Trump. The beat is a boost for the drugmaker as the wider sector braces for U.S. tariffs on pharmaceutical imports and navigates pricing challenges after Trump's order pushing for prices in the U.S. to fall to what other countries pay. The firm's shares rose around 1% in early trading on Tuesday. AstraZeneca, the UK's largest-listed company by market value, in April had forecast only a limited impact from potential U.S. tariffs on pharmaceutical imports, and said it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-U.S. trade deal over the weekend will result in a 15% tariff on pharmaceuticals from the region. The Anglo-Swedish drugmaker, which is targeting $80 billion in annual revenue by 2030, maintained its annual outlook and increased its interim dividend by 3%. "Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent," CEO Pascal Soriot said in a statement. Sales of AstraZeneca's oncology drugs, which make up nearly half of its revenue and are being weighed down by changes in U.S. Medicare price negotiations, were up 18% at $6.31 billion at constant currency rates for the three-month period ended June 30. Analysts at Jefferies said sales of key cancer drugs such as Tagrisso, Lynparza, Calquence, and Truqap and Imfinzi were ahead of expectations. Total revenue grew 11% to $14.46 billion, with core earnings of $2.17 per share, with double-digit growth in the U.S., which makes up more than 40% of sales. That compares with analysts' expectations of $14.15 billion and $2.16, respectively, according to a company-provided consensus. AstraZeneca, which is hoping to move on from scandals in its second-biggest market, China, where it also faces minor fines related to cancer drugs, said it was also fighting several patent challenges from an individual against Tagrisso.
Daily Mail
32 minutes ago
- Daily Mail
Spirit Airlines to furlough 270 pilots and demote another 140
Airlines were supposed to rake in record profits in 2025. Instead, another company is cutting hundreds of staffers. Spirit Airlines said on Monday it will furlough about 270 pilots while demoting another 140. It's the latest major move from the cash-strapped budget carrier, as it looks to scale down its workforce, downsized schedule, and return to profitability. The furloughs will go into effect on November 1, while designation downgrades for captains will take place on October 1, the company told Reuters in an emailed statement. 'We are taking necessary steps to ensure we operate as efficiently as possible as part of our efforts to return to profitability,' the airline said. The announcement, first reported by Bloomberg News, comes as Spirit tries to overhaul its business to move away from its no-frills image and rebrand as a premium airline. The Florida-based carrier had filed for bankruptcy protection last November, following years of losses, heavy debt, and failed merger attempts. It emerged from bankruptcy in March. The company needs fewer pilots to operate its flights, but that has sent off sparks inside the carrier. 'Spirit continues to shrink, and with it, the value of pilot seniority and Spirit careers continues to erode,' Captain Ryan Muller, chairman of the Spirit unit of the Air Line Pilots Association, said. Captain Muller added that this marks the third round of pilot furloughs and downgrades since September 2024. Spirit is not alone. Dozens of airlines have culled parts of their schedules, announced major layoffs, and cut back on financial expectations for 2025. The cuts have been particularly brutal for budget-friendly airlines.
Reuters
32 minutes ago
- Reuters
BetMGM raises 2025 forecast on strong iGaming, sports betting growth
July 29 (Reuters) - U.S. sports-betting service BetMGM, a joint venture between Entain (ENT.L), opens new tab and MGM Resorts (MGM.N), opens new tab, has raised its full-year 2025 revenue and core earnings forecast after posting a 35% rise in first-half revenue, helped by strong demand in online sports betting and its iGaming division. Growth in player volumes and engagement helped lift iGaming revenue by 28% in the first half, Entain said. Founded in 2018, BetMGM has been expanding its digital footprint to tap into the fast-growing U.S. e-betting market amid stiff competition. BetMGM now expects revenue of at least $2.7 billion and core earnings of at least $150 million in fiscal year 2025, Entain said. It had earlier forecast revenue of at least $2.6 billion, and earnings before interest, taxes, depreciation, and amortization of at least $100 million.
